Skip to main content
. 2019 Jul 11;110(8):2600–2606. doi: 10.1111/cas.14109

Table 3.

Cohort 2, myeloma cases (n = 120)

Molecule Sensitivity (95% CI) Specificity (95% CI) Accuracy (95% CI)
CCND1 1.00 (.87‐1.00) .98 (.93‐1.00) .98 (.94‐1.00)
NSD2 .92 (.64‐1.00) .99 (.95‐1.00) .98 (.94‐1.00)
MAF 1.00 (.40‐1.00) 1.00 (.97‐1.00) 1.00 (.97‐1.00)